Axillary lymph node dissection (ALND) is a procedure to remove lymph nodes in the underarm area when breast cancer has spread, aiming to prevent further spread and recurrence. The procedure involves ...
Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...
D. Scott Lind, M.D., F.A.C.S.; Barbara L. Smith, M.D., Ph.D., F.A.C.S.; Wiley W. Souba, M.D., Sc.D., F.A.C.S. Before the advent of SLN biopsy, axillary dissection was ...
Although numerous studies have shown that the status of the sentinel node is an accurate predictor of the status of the axillary nodes in breast cancer, the efficacy and safety of sentinel-node biopsy ...
A new procedure improves the accuracy of axillary staging and pathologic evaluation in clinically node-positive breast cancer, and reduces the need for a more invasive procedure with debilitating ...
Axillary vein puncture guided by ultrasound, using a readily learned technique, was superior to cephalic vein dissection via cut-down for implantation of cardiac device leads in a small, multicenter, ...
Clinical Use of Epidermal Growth Factor Receptor Testing in Patients With Advanced Lung Cancer by Physicians: Survey of US and International Patterns A prospectively maintained database was assessed ...
Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...
What is an Axillary Lymph Node Dissection? To understand this procedure, we have Dr. Hari Krishna Ahuja, Head of Oncology Department from Apollo Healthcare Hospital, Greater Noida. He says that lymph ...
The recent publication of the results of the American College of Surgeons Oncology Group trial Z0011 has generated substantial interest in the medical community and public press. 1,2 This trial ...
A new procedure developed by surgeons at The University of Texas MD Anderson Cancer Center improves the accuracy of axillary staging and pathologic evaluation in clinically node-positive breast cancer ...